Enterprise Introduction
Zhejiang Langhua Pharmaceutical Co.,Ltd, formerly as Zhejiang Xinhua Pharmaceutical Co.,Ltd established in year 1986, is a U.S.FDA approved pharmaceutical company, focusing on Fluoroquinolone, Anti-virus , Cardiovascular APIs & advanced intermediates manufacturer in China. We have been approved by FDA/WHO/EDQM/ANVISA for GMP, and granted with 1 EUGMP, 2 WHO-PQ GMP，2 Brazilian GMP certificates, 3 CEP certificates , 17 CFDA GMP certificates and 4 US-DMF. Beside the ISO 14001&OHSAS18001 certificates, we have good EHS system which has been approved by governmental authorities and multi-national pharmaceutical companies. We have professional and experienced R&D team constituted by Post-PhD, Doctors and Masters, over 10 years CMO experience, and dedicated pilot, scale-up workshop which complies with cGMP requirement. Can run ROS developing, lab trial, pilot, scaling-up, and commercial production, from Gram to Ton lot. Certificates: WHO-PQ: Zidovudine, Levofloxacin hemihydrate EUGMP: Zidovudine CEP: Zidovudine, Spironolactone, Enrofloxacin ANVISA GMP: Zidovudine, Ciprofloxacin HCl US-DMF: Zidovudine, Spironolactone, Levofloxacin hemihydrates, Enrofloxacin

Enterprise honor